BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38583005)

  • 1. Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour.
    Wang H; Zhang Y
    Arch Esp Urol; 2024 Mar; 77(2):135-141. PubMed ID: 38583005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
    Chen ZH; Cui MY; Zhang HM
    Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LINC01339 Hinders the Development of Wilms' Tumor via MiR-135b-3p/ADH1C Axis.
    Yu Y; Liu Y
    Horm Metab Res; 2024 Mar; 56(3):244-254. PubMed ID: 37890508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
    Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
    Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
    [No Abstract]   [Full Text] [Related]  

  • 5. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells.
    Che G; Gao H; Tian J; Hu Q; Xie H; Zhang Y
    Pediatr Dev Pathol; 2020; 23(2):144-151. PubMed ID: 31498707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
    Shen J; Shu Q
    Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-22-3p regulates the proliferation and invasion of Wilms' tumor cells by targeting AKT3.
    Luo B; Ma L; Xing X; Wang ZR; Teng Q; Li SG
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5996-6004. PubMed ID: 32572913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1.
    Guo ZT; Yu Q; Miao C; Ge W; Li P
    Mol Cell Biol; 2022 Aug; 42(8):e0039721. PubMed ID: 35862727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
    Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
    Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.
    Du J; Xiao J; Zhuo Y; Nie M; Yang J; Luo X; Gu H
    Anticancer Drugs; 2022 Sep; 33(8):720-730. PubMed ID: 35946509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-144-3p inhibits the proliferation and metastasis of pediatric Wilms' tumor cells by regulating Girdin.
    Liu CL; Wang WH; Sun YL; Zhuang HW; Xu M; Chen HF; Liu JX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7671-7678. PubMed ID: 30536309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-143-3p Inhibits Wilms' Tumor Cell Growth By Targeting the Ras/Raf/MEK/ERK Pathway.
    Zhang L; Shao W
    Altern Ther Health Med; 2023 Mar; 29(2):140-147. PubMed ID: 36455140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ-PRMT5 stimulates the proliferative ability in Wilms' tumor through the miR-7-5p/KLF4 axis.
    Zhang J; Quan Y; Su X; Qiu B; Dong Q
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):232-236. PubMed ID: 37715374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
    Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4145-4151. PubMed ID: 32373950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.
    Wang HF; Zhang YY; Zhuang HW; Xu M
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3360-3369. PubMed ID: 28829507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.